Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
Principal factor analysis of p...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.
Bibliográfalaš dieđut
Váldodahkkit:
Generali, D
,
Fox, S
,
Buffa, F
,
Berruti, A
,
Brizzi, M
,
Allevi, G
,
Bonardi, S
,
Dogliotti, L
,
Bottini, A
,
Harris, A
Materiálatiipa:
Conference item
Almmustuhtton:
2006
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Geahča maid
Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
Dahkki: Generali, D, et al.
Almmustuhtton: (2006)
Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
Dahkki: Generali, D, et al.
Almmustuhtton: (2006)
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
Dahkki: Generali, D, et al.
Almmustuhtton: (2009)
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
Dahkki: Mele, T, et al.
Almmustuhtton: (2010)
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
Dahkki: Mele, T, et al.
Almmustuhtton: (2010)